The New Organ Prize will be launched at the World Stem Cell Summit in San Diego on 4th December. The prize, created by the Methuselah Foundation, which promotes anti-ageing research, will go to the first scientist who grows and transplants a fully functioning organ from a patient’s own cells, hopefully within the next decade. The trophy is designed to revolutionise the field of regenerative medicine; currently, three people a day die in the UK waiting for a transplant. The pot has yet to be confirmed as it will be crowdfunded (www.neworgan.org).
Expect a buzz from 1st December, as an EU ban on neonicotinoid pesticides comes into effect. The EU has declared a two-year moratorium on three chemicals—clothianidin, imidacloprid, and thiamethoxam—because of fears they harm honey bees. The UK is among several countries that dispute the studies; the saga continues to raise important questions about the complex scientific decision-making processes underlying pan-European regulation.
Are you planning to tuck into turkey with all the trimmings this month? Perhaps it’s not the best time to draw your attention to a Nice consultation that closes in December on how to help the overweight keep the pounds off. The rethink on “lifestyle weight management services” suggests planning committees restricting the spread of fast food outlets in certain areas, rather than banning specific foods. Bring on the brandy custard!
You have now reached your limit of 3 free articles in the last 30 days.
But don’t worry! You can get another 7 articles absolutely free, simply by entering your email address in the box below.
When you register we’ll also send you a free e-book—Writing with punch—which includes some of the finest writing from our archive of 22 years. And we’ll also send you a weekly newsletter with the best new ideas in politics and philosophy of culture, which you can of course unsubscribe from at any time
Prospect may process your personal information for our legitimate business purposes, to provide you with our newsletter, subscription offers and other relevant information.
Click to learn more about these interests and how we use your data. You will be able to object to this processing on the next page and in all our communications.
